The largest database of trusted experimental protocols

Biologic duoflow quadtec 10 system

Manufactured by Bio-Rad
Sourced in United States

The BioLogic DuoFlow QuadTec 10 System is a versatile and automated chromatography system designed for various research and purification applications. It features four independent pump channels, allowing for flexible control and programming of multiple buffers or samples. The system is capable of monitoring multiple parameters, including UV, conductivity, and pH, providing real-time data for monitoring the purification process.

Automatically generated - may contain errors

8 protocols using biologic duoflow quadtec 10 system

1

Plasma Lipoprotein Profiling by FPLC

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasma lipoprotein profile was analyzed by FPLC as described 42 (link). Briefly, after 100 μl plasma was injected, lipoproteins were run at 0.5 ml/min in a buffer containing 0.15 M NaCl, 0.01 M Na2HPO4, 0.1 mM EDTA, pH 7.5, and separated on a Superose 6 10/300 GL column (GE Healthcare) by using BioLogic DuoFlow QuadTec 10 System (Bio-Rad, CA). 500 μl of sample per fraction was collected. Triglyceride or cholesterol levels in each fraction were determined using Infinity reagents (Thermo Fisher).
+ Open protocol
+ Expand
2

Quantification of Hepatic Lipids and Fatty Acids

Check if the same lab product or an alternative is used in the 5 most similar protocols
Approximately 100 mg liver was homogenized in methanol and lipids were extracted in chloroform/methanol (2:1 v/v) as described (33 (link)). Hepatic triglyceride and cholesterol levels were then quantified using Infinity reagents from Thermo Scientific (Waltham, MA). Hepatic fatty acid profile was quantified using gas chromatography (GC)-mass spectrometry at the Mouse Metabolic Phenotyping Center (MMPC) of Case Western Reserve University (Cleveland, OH). Hepatic total free fatty acids and free cholesterol were quantified using kits from BioVision (Milpitas, CA). Plasma lipid and glucose levels were also determined using Infinity reagents. Briefly, after 100 μl plasma was injected, lipoproteins were run at 0.5 ml/min in a buffer containing 0.15 M NaCl, 0.01 M Na2HPO4, 0.1 mM EDTA, pH 7.5, and separated on a Superose 6 10/300 GL column (GE Healthcare) by using BioLogic DuoFlow QuadTec 10 System (Bio-Rad, CA). 500 μl of sample per fraction was collected.
+ Open protocol
+ Expand
3

Hepatic Lipid Profiling and Plasma Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Approximately 100 mg liver was homogenized in methanol and lipids were extracted in chloroform/methanol (2:1 v/v) as described 43 (link). Hepatic triglyceride and cholesterol levels were then quantified using Infinity reagents from Thermo Scientific (Waltham, MA). Plasma lipid and glucose levels were also determined using Infinity reagents. Plasma lipoprotein profile was analyzed by FPLC as described 19 (link). Briefly, after 100 μl plasma was injected, lipoproteins were run at 0.5 ml/min in a buffer containing 0.15 M NaCl, 0.01 M Na2HPO4, 0.1 mM EDTA, pH 7.5, and separated on a Superose 6 10/300 GL column (GE Healthcare) by using BioLogic DuoFlow QuadTec 10 System (Bio-Rad, CA). 500 μl of sample per fraction was collected.
+ Open protocol
+ Expand
4

Lipoprotein Profiling by FPLC

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasma cholesterol (cat # TR13421), triglyceride (cat # TR22421), alanine aminotransferase (ALT; cat # TR71121), and aspartate aminotransferase (AST; cat # TR70121) levels were measured using Infinity reagents (ThermoFisher Scientific; Waltham, MA, USA). Plasma lipoproteins were separated by fast protein liquid chromatography (FPLC). In brief, more than 100 μL plasma was run at 0.5 mL/min in a buffer (0.15 mol/L NaCl, 0.01 mol/L Na2HPO4, 0.1 mmol/L EDTA, pH 7.5), and lipoproteins were separated on a Superose 6 10/300 GL column (GE Healthcare; Chicago, IL, USA) using BioLogic DuoFlow QuadTec 10 System (Bio-Rad; Hercules, CA, USA). The total cholesterol or triglyceride amount in each fraction (500 μL) was calculated after a small portion (50 μL) was used for quantification.
+ Open protocol
+ Expand
5

Hepatic Lipid Profiling and Plasma Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Approximately 100 mg liver was homogenized in methanol and lipids were extracted in chloroform/methanol (2:1 v/v) as described 43 (link). Hepatic triglyceride and cholesterol levels were then quantified using Infinity reagents from Thermo Scientific (Waltham, MA). Plasma lipid and glucose levels were also determined using Infinity reagents. Plasma lipoprotein profile was analyzed by FPLC as described 19 (link). Briefly, after 100 μl plasma was injected, lipoproteins were run at 0.5 ml/min in a buffer containing 0.15 M NaCl, 0.01 M Na2HPO4, 0.1 mM EDTA, pH 7.5, and separated on a Superose 6 10/300 GL column (GE Healthcare) by using BioLogic DuoFlow QuadTec 10 System (Bio-Rad, CA). 500 μl of sample per fraction was collected.
+ Open protocol
+ Expand
6

Purifying Virus-Like Particles for Imaging

Check if the same lab product or an alternative is used in the 5 most similar protocols
To increase purify of VLPs for VLP imaging, an additional 35% sucrose sedimentation was added to the extraction procedure as mentioned in Moon et al.32 (link). Gradients were fractionated by centrifugation at 90,000×g for 2 h. The final pellets were resuspended in sterile 50 mM potassium phosphate pH 7.0. To confirm self-assembled particle, the purified protein was analyzed by size exclusion chromatography using the BioLogic DuoFlow QuadTec 10 System (Bio-Rad) at the UNIST (Ulsan, Korea). Concentrated VLPs were subjected to negative staining and examination by transmission electron microscopy. Two microliters of each removed salt component suspensions were placed on 200-mesh copper grids (Electron Microscopy Sciences, Hatfield, PA, USA) and allowed to incubate at room temperature for 1 min in order for the particles to adhere. Two microliters of 1.5% uranyl acetate were added to the attached particles on the grid, grids were then analyzed by using a transmission electron microscope JEM-2100 (JEOL, Tokyo, Japan), and images were acquired through a CCD camera SIS veleta (Olympus, Munster, Germany) at the UNIST (Ulsan, Korea).
+ Open protocol
+ Expand
7

Comprehensive Lipid and Bile Acid Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasma TG (cat # TR22421), total cholesterol (cat # TR13421), ALT (TR71121) and AST (TR70121) were measured using Infinity reagents (Thermo Scientific). Plasma total bile acids were measured using a Total Bile Acid Test kit (Diazyme; cat #DZ042A-K). Plasma HDL-C levels were measured using an HDL and LDL/VLDL quantification kit (cat # K613, Biovision Inc). Plasma LDL-C levels were measured using a kit from Diazyme (DZ128A-KY1). Plasma ApoA-I (cat # EKF58103) and ApoB (cat # EKE61526) levels were measured using ELISA kits from Biomatic (Ontario, Canada). Bile acid composition in the bile was measured by HPLC according to the method of Rossi et al77 (link),78 (link). Plasma lipoproteins were separated by Biologic DuoFlow QuadTec 10 System (Bio-Rad) and TG or cholesterol levels in individual fractions were quantified. Hepatic lipids were extracted in chloroform/methanol (2:1, v/v), and 0.043% magnesium chloride was added. Lipids in the chloroform layer was used for radioactivity measurement.
+ Open protocol
+ Expand
8

Comprehensive Lipid and Bile Acid Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasma TG (cat # TR22421), total cholesterol (cat # TR13421), ALT (TR71121) and AST (TR70121) were measured using Infinity reagents (Thermo Scientific). Plasma total bile acids were measured using a Total Bile Acid Test kit (Diazyme; cat #DZ042A-K). Plasma HDL-C levels were measured using an HDL and LDL/VLDL quantification kit (cat # K613, Biovision Inc). Plasma LDL-C levels were measured using a kit from Diazyme (DZ128A-KY1). Plasma ApoA-I (cat # EKF58103) and ApoB (cat # EKE61526) levels were measured using ELISA kits from Biomatic (Ontario, Canada). Bile acid composition in the bile was measured by HPLC according to the method of Rossi et al77 (link),78 (link). Plasma lipoproteins were separated by Biologic DuoFlow QuadTec 10 System (Bio-Rad) and TG or cholesterol levels in individual fractions were quantified. Hepatic lipids were extracted in chloroform/methanol (2:1, v/v), and 0.043% magnesium chloride was added. Lipids in the chloroform layer was used for radioactivity measurement.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!